Use of PDE4 inhibitors for the treatment of diabetes mellitus

Details for Australian Patent Application No. 2004269923 (hide)

International Classifications

Event Publications

27 April 2006 PCT application entered the National Phase

PCT publication WO2005/023253 Priority application(s): WO2005/023253

4 May 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 30 Mar 2006

22 November 2007 Change of Name(s) of Applicant(s), Section 104

ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH

13 May 2010 Application Accepted

Published as AU-B-2004269923

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.